Overview

Atorvastatin Therapy on Xanthoma in Alagille Syndrome

Status:
Recruiting
Trial end date:
2025-03-22
Target enrollment:
Participant gender:
Summary
To observe the efficacy and safety of atorvastatin on xanthoma in Alagille syndrome through a prospective study.
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital of Fudan University
Treatments:
Atorvastatin